MOSS, MD, R. B.; CARLETON, PHD, F.; LOLLO, PHD, C. P.; CARLO, PHD, D. J. An open-label, randomized, single-dose, two-period, two-treatment crossover bioavailability study comparing 5 mg/0.5 mL of intramuscular naloxone hydrochloride to 2 mg/0.4 mL intramuscular naloxone hydrochloride autoinjector in healthy subjects. Journal of Opioid Management, [S. l.], v. 16, n. 3, p. 209–214, 2020. DOI: 10.5055/jom.2020.0569. Disponível em: https://wmpllc.org/ojs/index.php/jom/article/view/2747. Acesso em: 4 may. 2024.